ID: ALA3887699
Type: Binding
Description: Inhibition Assay: A rapid plate DNA synthesis assay was performed using optimized conditions. Briefly, a 1.2:1 ratio of a 20-mer oligonucleotide primer (5′-GCGAATGAATGACCGCTGAC-3′, SEQ ID No. 1) and a 5′-end biotinylated 100-mer oligonucleotide template (5′-Biotin-AGCACTATTGACATTACAGAGTCGCCTTGGCTCTCTGGCTGTTCGTTGCGGGCTCCGCG TGCGTTGGCTTCGGTCGTCCCGTCAGCGGTCATTCATTGGC-3′) were annealed and loaded into a 96-well microtiter streptavidin-coated plate (Streptawell plates, Roche Applied Science, Indianapolis, Ind., USA) at 5 pmol/well. The wells were incubated at 37 C for 90 min, and washed with 100 L PBS. The reaction was conducted in low salt buffer (20 mM Tris-HCl pH 7.4, 3 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 2% glycerol, 40 ug/mL BSA, 5 uM dNTPs, 1 uM digoxigenin-11-2′-deoxyuridine-5′-triphosphate (DIG-dUTP, Roche Applied Science) with 1 μL vaccinia infected cell lysate or 1 uL of in vitro translated E9 DNA polymerase. The reaction plates were incubated at 37° C
Bioactivity
Activity Types for Assay ALA3887699
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
467.21 | 3.59 | 3.59 |
382.51 | 5.27 | 5.27 |
316.16 | 3.69 | 3.69 |
319.43 | 5.03 | 5.03 |
363.51 | 5.07 | 5.07 |
335.45 | 4.24 | 4.24 |
327.43 | 5.95 | 5.95 |
329.44 | 3.39 | 3.39 |
309.42 | 3.61 | 3.61 |
293.37 | 3.83 | 3.83 |
434.54 | 4.11 | 4.11 |
319.45 | 4.59 | 4.59 |
326.83 | 4.22 | 4.22 |
400.53 | 4.62 | 4.62 |
266.27 | 1.95 | 1.95 |
231.26 | 1.25 | 1.25 |
373.91 | 4.32 | 4.32 |
427.96 | 5.21 | 5.21 |
253.26 | 2.68 | 2.68 |
359.40 | 3.48 | 3.48 |
289.34 | 3.29 | 3.29 |
333.46 | 2.63 | 2.63 |
404.99 | 5.06 | 5.06 |
271.10 | 3.75 | 3.75 |
395.27 | 5.20 | 5.20 |
359.38 | 4.75 | 4.75 |
353.30 | 3.25 | 3.25 |
317.80 | 4.98 | 4.98 |
277.33 | 2.79 | 2.79 |
311.73 | 3.48 | 3.48 |
324.32 | 2.04 | 2.04 |
230.29 | 3.22 | 3.22 |
248.32 | 2.56 | 2.56 |
296.32 | 1.42 | 1.42 |
475.96 | 5.73 | 5.73 |